These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 8569021)
1. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. Chopra I; Hodgson J; Metcalf B; Poste G JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021 [No Abstract] [Full Text] [Related]
2. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. Tomasz A N Engl J Med; 1994 Apr; 330(17):1247-51. PubMed ID: 8139650 [No Abstract] [Full Text] [Related]
3. Antibiotic resistance--problems, progress, and prospects. Nathan C; Cars O N Engl J Med; 2014 Nov; 371(19):1761-3. PubMed ID: 25271470 [No Abstract] [Full Text] [Related]
4. Antibiotics that resist resistance. Service RF Science; 1995 Nov; 270(5237):724-7. PubMed ID: 7481757 [No Abstract] [Full Text] [Related]
5. Drug-resistant bacteria: responding to the infectious disease crisis. Jack DB Mol Med Today; 1996 Dec; 2(12):499-502. PubMed ID: 9015790 [TBL] [Abstract][Full Text] [Related]
6. Who or what is the source of antibiotic resistance? Bergogne-Bérézin E J Med Microbiol; 1997 Jun; 46(6):461-4. PubMed ID: 9379476 [No Abstract] [Full Text] [Related]
8. The millennium bugs--the need for and development of new antibacterials. Bax R; Mullan N; Verhoef J Int J Antimicrob Agents; 2000 Sep; 16(1):51-9. PubMed ID: 11185414 [TBL] [Abstract][Full Text] [Related]
9. Development of antibiotic resistance: a vet's tale. Wray C J Med Microbiol; 1997 Jan; 46(1):26-33. PubMed ID: 9003742 [No Abstract] [Full Text] [Related]
11. Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tactic. Amábile-Cuevas CF; Heinemann JA Drug Discov Today; 2004 Jun; 9(11):465-7. PubMed ID: 15149615 [No Abstract] [Full Text] [Related]
12. The business of developing antibacterials. Fox JL Nat Biotechnol; 2006 Dec; 24(12):1521-8. PubMed ID: 17160056 [TBL] [Abstract][Full Text] [Related]
13. Novel agents to inhibit microbial virulence and pathogenicity. Escaich S Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591 [TBL] [Abstract][Full Text] [Related]
14. Approaches targeting the type III secretion system to treat or prevent bacterial infections. Charro N; Mota LJ Expert Opin Drug Discov; 2015 Apr; 10(4):373-87. PubMed ID: 25727140 [TBL] [Abstract][Full Text] [Related]
16. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283 [TBL] [Abstract][Full Text] [Related]
17. Overcoming antimicrobial resistance by targeting resistance mechanisms. Poole K J Pharm Pharmacol; 2001 Mar; 53(3):283-94. PubMed ID: 11291743 [TBL] [Abstract][Full Text] [Related]
18. Microbial resistance to antibiotics. An evolving and persistent problem. Levy SB Lancet; 1982 Jul; 2(8289):83-8. PubMed ID: 6123819 [No Abstract] [Full Text] [Related]
19. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs]. Gintsburg AL; Zigangirova NA; Zorina VV Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396 [TBL] [Abstract][Full Text] [Related]